ISPOR Educational Webinar Series on Good Practices for Outcomes Research

What is the ISPOR Educational Webinar Series?
ISPOR Educational Webinars is a series on the ISPOR Good Practices for Outcomes Research Reports that serves to promote the use of good research practices and to further educate on key outcomes research methods. With these series participants will have the opportunity to learn about best methodology practices for outcomes research directly from the authors. Please see the box below for a list of all Upcoming Educational Webinars.

Next in Educational Webinars Series

TBD

Leveraging Data Science and Innovative Digital Technologies to Optimize Real World Evidence Generation

Tuesday, June 12, 2018 | 10:00AM EDT | 4:00PM CEST

Presenters:
Jyotsna Mehta, Founder, KEVA Health
Bill Fox, Chief Strategist, Global Healthcare, Life Sciences and Insurance, MarkLogic
Dr. Javier Jimenez, Vice President, Global Head RWE and Clinical Outcomes, Sanofi
Dr. Ashish Atreja, Chief Innovation Officer, Medicine, Mount Sinai Health System

Open to all –ISPOR Members and Non-Members

Previously Recorded Webinars

Modeling Methods
Uwe Siebert, MD,

Uwe Siebert, MD, MPH, MSc, ScD
Professor of Public Health, UMIT - Univ. of Health Sciences, Medical Informatics & Technology, Hall i.T, Austria

Karen Kuntz, ScD
Professor, University of Minnesota School of Public Health, Minneapolis, MN USA
Beate Jahn, PhD
Researcher, UMIT - Univ. of Health Sciences, Medical Informatics & Technology, Hall, i.T, Austria
Jaime Caro

J. Jaime Caro, MDCM, FRCPC, FACP
Senior Vice President, Research, Evidera, Lexington, MA, USA and Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ, Canada

Andrew Briggs, DPhil, MSc

Andrew Briggs, DPhil, MSc
William R. Lindsay Chair of Health Economics, Health Economics & Health Technology Assessment Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK

Jonathan Karnon

Jonathan Karnon, PhD, Professor in Health Economics, School of Population Health and Clinical Practice, University of Adelaide
Adelaide, Australia

James Stahl

James Stahl, MDCM, MPH, Senior Scientist, MGH Institute for Technology Assessment and Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Mark S. Roberts, MD, MPP

Mark S. Roberts, MD, MPP, Professor & Chair, Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health
Pittsburgh, PA, USA

Kalyan S. Pasupathy, PhD

Kalyan S. Pasupathy, PhD
Faculty, Healthcare Policy & Research and Co-Scientific Director, Healthcare Systems Engineering Program,
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery,
Rochester, MN, USA

William V. Padula, PhD, MS

William V. Padula, PhD, MS
Postdoctoral Fellow, Section of Hospital Medicine
University of Chicago, Chicago, IL, USA
Rochester, MN, USA

Peter Wong, PhD, MS, MBA, RPh

Peter Wong, PhD, MS, MBA, RPh
Vice President & Chief Performance Improvement Officer, Illinois Divisions and HSHS Medical Group
Hospital Sisters Health System (HSHS)
Belleville, IL, USA

Economic Evaluation Methods
Don Husereau, BScPharm, MSc

Don Husereau, BScPharm, MSc, Adjunct Professor, Faculty of Medicine at the University of Ottawa, Ottawa, ON, Canada, and Senior Scientist, University for Health Sciences, Medical Informatics and Technology
Hall in Tirol, Austria

Michael Drummond, PhD

Michael Drummond, PhD, Co-Editor-in-Chief, Value in Health and Professor of Health Economics, Centre for Health Economics, University of York
Heslington, York, UK

Josephine Mauskopf

Josephine Mauskopf, PhD, MHA, MA
Vice President, Health Economics, RTI Health Solutions
Research Triangle Park, NC, USA

Daniel Mullins

C. Daniel Mullins, PhD, Professor, Pharmaceutical Health Services Researc, University of Maryland School of Pharmacyh
Baltimore, MD, USA

 Scott Ramsey

Scott D. Ramsey, MD, PhD
Member, Fred Hutchinson Cancer Research Center
and Professor, Department of Medicine, University of Washington
Seattle, WA, USA

Richard Willke

Richard J. Willke, PhD
Vice President, Outcomes & Evidence, Global Health & Value
Pfizer Inc., New York, NY, USA

Observational Study Methods-Database Methods
Jyotsna Mehta

Jyotsna Mehta
Founder
KEVA Health (Knowledge Evidence Value Access)

Bill Fox

Bill Fox
Chief Strategist
Global Healthcare, Life Sciences and Insurance
MarkLogic

Dr. Javier Jimenez

Dr. Javier Jimenez
Vice President, Global Head, RWE and Clinical Outcomes
Sanofi

Dr. Javier Jimenez

Dr. Ashish Atreja
Chief Innovation Officer, Medicine
Mount Sinai Health System

Patient-Reported & Clinician-Reported Outcomes Method
John H. Powers, III, MD FACP FIDSA

John H. Powers III, MD FACP FIDSA
Associate Clinical Professor of Medicine
George Washington University, School of Medicine
Washington, DC, USA

Sonya Eremenco, MA

Sonya Eremenco, MA, Director, ePRO New Products, Evidera
Bethesda, MD, USA

Stephen Joel Coons, PhD

Stephen Joel Coons, PhD, Executive Director, Patient-Reported Outcome Consortium
Critical Path Institute, Tucson, AZ, USA

Antonia V. Bennett, PhD

Antonia V. Bennett, PhD, Assistant Professor, Department of Health Policy and Management
University of North Carolina, Chapel Hill, NC, USA

Preference-Based Methods
Sorrel Wolowacz, PhD

Sorrel Wolowacz, PhD
Head, European Health Economics, RTI Health Solutions, Manchester, United Kingdom

Andrew Briggs, DPhil, MSc

Andrew Briggs, DPhil, MSc
Professor of Health Economics, Institute of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom

Lynda Doward, MRes

Lynda Doward, MRes
European Head, Patient-Reported Outcomes, RTI Health Solutions, Manchester, United Kingdom

Andrew Lloyd, DPhil

Andrew Lloyd, DPhil
Director, Bladon Associates Ltd, Oxford, United Kingdom

Use of Outcomes Research in Health Care Decisions
Finn Borlum Kristensen, PhD

Finn Børlum Kristensen, MD, PhD
Professor, Health Services Research and HTA
University of Southern Denmark
Odense, Denmark

Louis P Garrison, Jr, PhD

Louis P Garrison, Jr, PhD
Professor, Pharmaceutical Outcomes Research & Policy Program
School of Pharmacy, University of Washington
Seattle, WA, USA

Richard J. Willke, PhD

Richard J. Willke, PhD
Chief Science Officer
ISPOR, Lawrenceville, USA

Lucinda Orsini, DPM, MPH

Lucinda Orsini, DPM, MPH
Associate Chief Science Officer
University of Arkansas for Medical Sciences College of Pharmacy
ISPOR, Lawrenceville, USA

Marc Berger, MD

Marc Berger, MD
Vice President, Real World Data and Analytics
Pfizer
New York, NY, USA

Bradley Martin, PharmD, PhD, RPh

Bradley Martin, PharmD, PhD, RPh
Professor & Head, Division of Pharmaceutical Evaluation and Policy,
University of Arkansas for Medical Sciences College of Pharmacy
Little Rock, AR, USA

Jaime Caro

J. Jaime Caro, MDCM, FRCPC, FACP
Senior Vice President, Research, Evidera, Lexington, MA, USA and
Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canda

Jeroen Jansen, PhD

Jeroen P. Jansen, PhD
Founding Partner & Director Redwood Outcomes
San Francisco, CA, USA

Lou Garrison, PhD

Lou Garrison, PhD
Professor, Pharmaceutical Outcomes Research and Policy Program
Department of Pharmacy, University of Washington
Seattle, WA, USA

Adrian Towse, MA, MPhil

Adrian Towse, MA, MPhil
2014-2015 ISPOR President and
Director, Office of Health Economics
London, UK

Nancy Devlin, PhD

Nancy Devlin, PhD
Director of Research
Office of Health Economics
London, UK

Kevin Marsh, PhD

Kevin Marsh, PhD
Senior Research Scientist
EU Director of Modelling and Simulation
Evidera
London, UK

Praveen Thokala, PhD

Praveen Thokala, PhD, MASc
Research Fellow
School of Health and Related Research (ScHARR)
University of Sheffield
Sheffield, UK

ISPOR Education Index